Brooklyn Investment Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.71M Buy
19,747
+3,760
+24% +$360K 0.05% 334
2025
Q4
$1.54M Buy
15,987
+8,750
+121% +$850K 0.07% 229
2025
Q3
$622K Sell
7,237
-619
-8% -$56.9K 0.08% 236
2025
Q2
$685K Buy
7,856
+1,333
+20% +$113K 0.09% 218
2025
Q1
$586K Buy
6,523
+1,910
+41% +$171K 0.13% 159
2024
Q4
$368K Buy
4,613
+1,455
+46% +$126K 0.11% 158
2024
Q3
$284K Sell
3,158
-395
-11% -$33.2K 0.09% 186
2024
Q2
$309K Hold
3,553
0.13% 158
2024
Q1
$309K Buy
3,553
+494
+16% +$42.2K 0.13% 158
2023
Q4
$252K Buy
+3,059
New +$233K 0.12% 179

Other funds holding MDT

Brooklyn Investment Group's MDT Position: Q1 2026 in Review

Brooklyn Investment Group increased its Medtronic (MDT) stake by 24% in Q1 2026, buying an estimated $360K and bringing the position to 19,747 shares worth $1.71M. The position accounts for 0.05% of the portfolio, ranked #334.

Brooklyn Investment Group first reported a position in MDT in Q4 2023 and has held it in 10 quarters since. 2,246 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Brooklyn Investment Group held 19,747 shares of Medtronic worth $1.71M as of Q1 2026.
  • Brooklyn Investment Group bought 3,760 Medtronic shares in Q1 2026, an estimated $360K.
  • Medtronic made up 0.05% of Brooklyn Investment Group's portfolio in Q1 2026, its #334 holding.
  • Brooklyn Investment Group first reported a position in Medtronic in Q4 2023 and has held it in 10 quarters since.
  • 2,246 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.